Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort studyBMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k495 (Published 31 January 2018) Cite this as: BMJ 2018;360:k495
The results section of this Research paper (BMJ 2017;359:j4788, doi:10.1136/bmj.j4788), contained an error. Data under the heading “Prevalence of myocardial infarction and positive predictive value of cardiac troponin in selected patients (UK)” were inadvertently replaced with US data from the paragraph below. The second sentence should read “Type 1 myocardial infarction was adjudicated in 843 (14.5%) patients, with 229 (3.9%) patients classified as having type 2 myocardial infarction and 341 (5.9%) as having myocardial injury.” The PDF for the paper has been amended.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.